About Powerful Medical
Powerful Medical provides AI-powered cardiac care from instant ECG interpretation to acute pathway coordination, screening, and monitoring.
Mission & Story
Mission
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world's leading cause of death.
Clinical Focus
Medical conditions and clinical areas addressed by Powerful Medical.
Who It Serves
Milestones & Awards
Recent Milestones
Received €40 million IPCEI non-dilutive grant (2025). Won MedTech Innovator 2025. FDA Breakthrough Device Designation for PMcardio STEMI AI ECG Model (2025). Launched PMcardio for Individuals 3.0 (2025). AZORG deployment results showing 48-minute treatment time reduction (2026).
Awards & Recognition
MedTech Innovator 2025 winner. FDA Breakthrough Device Designation. Featured at ACC (American College of Cardiology) and TCT (Transcatheter Cardiovascular Therapeutics) 2025.
Key Partnerships
Social & Media
Follow on
Latest Updates
AI vs MD ECG-Reading for Cath Lab Activation (This Week in Cardiology, by Dr. John Mandrola)
Powerful Medical Wins MedTech Innovator 2025
PMcardio Expands Heart Attack Detection to Patient Bedside through Roche cobas® pulse Point of Care Platform
AZORG Hospitals Cut Subtle Heart Attack Treatment Delays by Several Hours with PMcardio Platform
Powerful Medical Receives €40 Million Non-Dilutive Grant to Accelerate Early Diagnosis of Cardiovascular Diseases with AI
Company Details
- Founded
- 2019
- Headquarters
- New York, NY, USA
- Employees
- 50
- Stage
- series a
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Artrya
11-50 employees
Artrya develops AI-powered solutions for rapid assessment of chest pain patients in emergency and primary care settings. The company's technology analyzes coronary computed tomography angiography (CCTA) to detect arterial plaque and stratify patient risk within minutes.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.